nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP3A4—Ifosfamide—testicular cancer	0.127	0.272	CbGbCtD
Dihydrocodeine—CYP2D6—Vinblastine—testicular cancer	0.106	0.227	CbGbCtD
Dihydrocodeine—CYP3A4—Vinblastine—testicular cancer	0.0673	0.144	CbGbCtD
Dihydrocodeine—CYP2D6—Doxorubicin—testicular cancer	0.0651	0.139	CbGbCtD
Dihydrocodeine—CYP3A4—Etoposide—testicular cancer	0.0607	0.13	CbGbCtD
Dihydrocodeine—CYP3A4—Doxorubicin—testicular cancer	0.0414	0.0886	CbGbCtD
Dihydrocodeine—Ileus paralytic—Vinblastine—testicular cancer	0.0276	0.0517	CcSEcCtD
Dihydrocodeine—Hallucination—Chlorambucil—testicular cancer	0.0065	0.0122	CcSEcCtD
Dihydrocodeine—Urinary retention—Ifosfamide—testicular cancer	0.00594	0.0111	CcSEcCtD
Dihydrocodeine—Angioedema—Chlorambucil—testicular cancer	0.00519	0.00975	CcSEcCtD
Dihydrocodeine—Convulsion—Chlorambucil—testicular cancer	0.00493	0.00925	CcSEcCtD
Dihydrocodeine—Vertigo—Vinblastine—testicular cancer	0.00468	0.00879	CcSEcCtD
Dihydrocodeine—Confusional state—Chlorambucil—testicular cancer	0.00468	0.00878	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Ifosfamide—testicular cancer	0.00455	0.00854	CcSEcCtD
Dihydrocodeine—Convulsion—Vinblastine—testicular cancer	0.00451	0.00847	CcSEcCtD
Dihydrocodeine—Hepatic enzyme increased—Methotrexate—testicular cancer	0.0043	0.00808	CcSEcCtD
Dihydrocodeine—Hallucination—Ifosfamide—testicular cancer	0.0043	0.00807	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Ifosfamide—testicular cancer	0.00427	0.00801	CcSEcCtD
Dihydrocodeine—Urethral disorder—Ifosfamide—testicular cancer	0.00423	0.00795	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00401	0.00752	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Cisplatin—testicular cancer	0.00392	0.00736	CcSEcCtD
Dihydrocodeine—Angiopathy—Ifosfamide—testicular cancer	0.00392	0.00736	CcSEcCtD
Dihydrocodeine—Immune system disorder—Ifosfamide—testicular cancer	0.0039	0.00732	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Ifosfamide—testicular cancer	0.00389	0.00731	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Chlorambucil—testicular cancer	0.00382	0.00718	CcSEcCtD
Dihydrocodeine—Paraesthesia—Vinblastine—testicular cancer	0.00382	0.00717	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00379	0.00712	CcSEcCtD
Dihydrocodeine—Mental disorder—Ifosfamide—testicular cancer	0.00378	0.0071	CcSEcCtD
Dihydrocodeine—Urticaria—Chlorambucil—testicular cancer	0.00369	0.00692	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Cisplatin—testicular cancer	0.00368	0.0069	CcSEcCtD
Dihydrocodeine—Abdominal pain—Chlorambucil—testicular cancer	0.00367	0.00688	CcSEcCtD
Dihydrocodeine—Urethral disorder—Cisplatin—testicular cancer	0.00365	0.00685	CcSEcCtD
Dihydrocodeine—Constipation—Vinblastine—testicular cancer	0.00364	0.00682	CcSEcCtD
Dihydrocodeine—Confusional state—Bleomycin—testicular cancer	0.00362	0.0068	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Etoposide—testicular cancer	0.00359	0.00675	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Vinblastine—testicular cancer	0.0035	0.00658	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00348	0.00653	CcSEcCtD
Dihydrocodeine—Angioedema—Ifosfamide—testicular cancer	0.00344	0.00645	CcSEcCtD
Dihydrocodeine—Vertigo—Ifosfamide—testicular cancer	0.00338	0.00634	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Etoposide—testicular cancer	0.00337	0.00632	CcSEcCtD
Dihydrocodeine—Immune system disorder—Cisplatin—testicular cancer	0.00336	0.00631	CcSEcCtD
Dihydrocodeine—Abdominal pain—Vinblastine—testicular cancer	0.00336	0.00631	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Cisplatin—testicular cancer	0.00336	0.0063	CcSEcCtD
Dihydrocodeine—Hypotension—Bleomycin—testicular cancer	0.00336	0.0063	CcSEcCtD
Dihydrocodeine—Urethral disorder—Etoposide—testicular cancer	0.00334	0.00628	CcSEcCtD
Dihydrocodeine—Pruritus—Chlorambucil—testicular cancer	0.00328	0.00616	CcSEcCtD
Dihydrocodeine—Convulsion—Ifosfamide—testicular cancer	0.00326	0.00612	CcSEcCtD
Dihydrocodeine—Paraesthesia—Bleomycin—testicular cancer	0.00322	0.00605	CcSEcCtD
Dihydrocodeine—Dyspnoea—Bleomycin—testicular cancer	0.0032	0.00601	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00318	0.00597	CcSEcCtD
Dihydrocodeine—Diarrhoea—Chlorambucil—testicular cancer	0.00317	0.00596	CcSEcCtD
Dihydrocodeine—Angiopathy—Etoposide—testicular cancer	0.0031	0.00581	CcSEcCtD
Dihydrocodeine—Confusional state—Ifosfamide—testicular cancer	0.00309	0.00581	CcSEcCtD
Dihydrocodeine—Immune system disorder—Etoposide—testicular cancer	0.00308	0.00578	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Etoposide—testicular cancer	0.00307	0.00577	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Ifosfamide—testicular cancer	0.00301	0.00565	CcSEcCtD
Dihydrocodeine—Skin disorder—Ifosfamide—testicular cancer	0.00298	0.0056	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00297	0.00557	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Bleomycin—testicular cancer	0.00296	0.00555	CcSEcCtD
Dihydrocodeine—Vomiting—Chlorambucil—testicular cancer	0.00295	0.00554	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vinblastine—testicular cancer	0.00291	0.00546	CcSEcCtD
Dihydrocodeine—Hypotension—Ifosfamide—testicular cancer	0.00287	0.00538	CcSEcCtD
Dihydrocodeine—Urticaria—Bleomycin—testicular cancer	0.00285	0.00535	CcSEcCtD
Dihydrocodeine—Dizziness—Vinblastine—testicular cancer	0.00281	0.00528	CcSEcCtD
Dihydrocodeine—Convulsion—Cisplatin—testicular cancer	0.00281	0.00527	CcSEcCtD
Dihydrocodeine—Mood swings—Methotrexate—testicular cancer	0.0028	0.00525	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Dactinomycin—testicular cancer	0.00276	0.00518	CcSEcCtD
Dihydrocodeine—Nausea—Chlorambucil—testicular cancer	0.00276	0.00517	CcSEcCtD
Dihydrocodeine—Paraesthesia—Ifosfamide—testicular cancer	0.00276	0.00517	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00274	0.00514	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00274	0.00514	CcSEcCtD
Dihydrocodeine—Dyspnoea—Ifosfamide—testicular cancer	0.00274	0.00514	CcSEcCtD
Dihydrocodeine—Somnolence—Ifosfamide—testicular cancer	0.00273	0.00512	CcSEcCtD
Dihydrocodeine—Affect lability—Epirubicin—testicular cancer	0.00272	0.00511	CcSEcCtD
Dihydrocodeine—Vomiting—Vinblastine—testicular cancer	0.0027	0.00507	CcSEcCtD
Dihydrocodeine—Vertigo—Etoposide—testicular cancer	0.00267	0.00501	CcSEcCtD
Dihydrocodeine—Headache—Vinblastine—testicular cancer	0.00266	0.005	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00265	0.00497	CcSEcCtD
Dihydrocodeine—Abdominal pain—Dactinomycin—testicular cancer	0.00265	0.00497	CcSEcCtD
Dihydrocodeine—Constipation—Ifosfamide—testicular cancer	0.00262	0.00493	CcSEcCtD
Dihydrocodeine—Mood swings—Epirubicin—testicular cancer	0.00262	0.00492	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Cisplatin—testicular cancer	0.00259	0.00487	CcSEcCtD
Dihydrocodeine—Convulsion—Etoposide—testicular cancer	0.00257	0.00483	CcSEcCtD
Dihydrocodeine—Skin disorder—Cisplatin—testicular cancer	0.00257	0.00482	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Cisplatin—testicular cancer	0.00256	0.0048	CcSEcCtD
Dihydrocodeine—Pruritus—Bleomycin—testicular cancer	0.00254	0.00477	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Ifosfamide—testicular cancer	0.00253	0.00475	CcSEcCtD
Dihydrocodeine—Nausea—Vinblastine—testicular cancer	0.00253	0.00474	CcSEcCtD
Dihydrocodeine—Affect lability—Doxorubicin—testicular cancer	0.00252	0.00473	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00251	0.00471	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00251	0.00471	CcSEcCtD
Dihydrocodeine—Hypotension—Cisplatin—testicular cancer	0.00247	0.00464	CcSEcCtD
Dihydrocodeine—Confusional state—Etoposide—testicular cancer	0.00244	0.00459	CcSEcCtD
Dihydrocodeine—Urticaria—Ifosfamide—testicular cancer	0.00244	0.00458	CcSEcCtD
Dihydrocodeine—Abdominal pain—Ifosfamide—testicular cancer	0.00243	0.00455	CcSEcCtD
Dihydrocodeine—Mood swings—Doxorubicin—testicular cancer	0.00242	0.00455	CcSEcCtD
Dihydrocodeine—Paraesthesia—Cisplatin—testicular cancer	0.00238	0.00446	CcSEcCtD
Dihydrocodeine—Dyspnoea—Cisplatin—testicular cancer	0.00236	0.00443	CcSEcCtD
Dihydrocodeine—Skin disorder—Etoposide—testicular cancer	0.00235	0.00442	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Etoposide—testicular cancer	0.00234	0.0044	CcSEcCtD
Dihydrocodeine—Diarrhoea—Dactinomycin—testicular cancer	0.00229	0.0043	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00228	0.00429	CcSEcCtD
Dihydrocodeine—Vomiting—Bleomycin—testicular cancer	0.00228	0.00429	CcSEcCtD
Dihydrocodeine—Hypotension—Etoposide—testicular cancer	0.00227	0.00425	CcSEcCtD
Dihydrocodeine—Rash—Bleomycin—testicular cancer	0.00226	0.00425	CcSEcCtD
Dihydrocodeine—Dermatitis—Bleomycin—testicular cancer	0.00226	0.00425	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Cisplatin—testicular cancer	0.00218	0.00409	CcSEcCtD
Dihydrocodeine—Paraesthesia—Etoposide—testicular cancer	0.00218	0.00409	CcSEcCtD
Dihydrocodeine—Pruritus—Ifosfamide—testicular cancer	0.00217	0.00408	CcSEcCtD
Dihydrocodeine—Dyspnoea—Etoposide—testicular cancer	0.00216	0.00406	CcSEcCtD
Dihydrocodeine—Somnolence—Etoposide—testicular cancer	0.00215	0.00404	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Methotrexate—testicular cancer	0.00215	0.00404	CcSEcCtD
Dihydrocodeine—Nausea—Bleomycin—testicular cancer	0.00213	0.004	CcSEcCtD
Dihydrocodeine—Vomiting—Dactinomycin—testicular cancer	0.00213	0.004	CcSEcCtD
Dihydrocodeine—Rash—Dactinomycin—testicular cancer	0.00211	0.00396	CcSEcCtD
Dihydrocodeine—Diarrhoea—Ifosfamide—testicular cancer	0.0021	0.00394	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00209	0.00393	CcSEcCtD
Dihydrocodeine—Constipation—Etoposide—testicular cancer	0.00207	0.00389	CcSEcCtD
Dihydrocodeine—Dizziness—Ifosfamide—testicular cancer	0.00203	0.00381	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Methotrexate—testicular cancer	0.00202	0.00379	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Epirubicin—testicular cancer	0.00201	0.00378	CcSEcCtD
Dihydrocodeine—Urethral disorder—Methotrexate—testicular cancer	0.002	0.00376	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Etoposide—testicular cancer	0.002	0.00375	CcSEcCtD
Dihydrocodeine—Nausea—Dactinomycin—testicular cancer	0.00199	0.00373	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Etoposide—testicular cancer	0.00198	0.00372	CcSEcCtD
Dihydrocodeine—Vomiting—Ifosfamide—testicular cancer	0.00195	0.00366	CcSEcCtD
Dihydrocodeine—Rash—Ifosfamide—testicular cancer	0.00194	0.00363	CcSEcCtD
Dihydrocodeine—Dermatitis—Ifosfamide—testicular cancer	0.00193	0.00363	CcSEcCtD
Dihydrocodeine—Urticaria—Etoposide—testicular cancer	0.00193	0.00361	CcSEcCtD
Dihydrocodeine—Abdominal pain—Etoposide—testicular cancer	0.00192	0.0036	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Epirubicin—testicular cancer	0.00189	0.00354	CcSEcCtD
Dihydrocodeine—Urethral disorder—Epirubicin—testicular cancer	0.00187	0.00352	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00186	0.0035	CcSEcCtD
Dihydrocodeine—Angiopathy—Methotrexate—testicular cancer	0.00185	0.00348	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methotrexate—testicular cancer	0.00185	0.00346	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methotrexate—testicular cancer	0.00184	0.00346	CcSEcCtD
Dihydrocodeine—Nausea—Ifosfamide—testicular cancer	0.00182	0.00342	CcSEcCtD
Dihydrocodeine—Diarrhoea—Cisplatin—testicular cancer	0.00181	0.0034	CcSEcCtD
Dihydrocodeine—Mental disorder—Methotrexate—testicular cancer	0.00179	0.00336	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—testicular cancer	0.00175	0.00328	CcSEcCtD
Dihydrocodeine—Angiopathy—Epirubicin—testicular cancer	0.00174	0.00326	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—testicular cancer	0.00173	0.00326	CcSEcCtD
Dihydrocodeine—Immune system disorder—Epirubicin—testicular cancer	0.00173	0.00324	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Epirubicin—testicular cancer	0.00172	0.00324	CcSEcCtD
Dihydrocodeine—Pruritus—Etoposide—testicular cancer	0.00171	0.00322	CcSEcCtD
Dihydrocodeine—Vomiting—Cisplatin—testicular cancer	0.00168	0.00316	CcSEcCtD
Dihydrocodeine—Mental disorder—Epirubicin—testicular cancer	0.00168	0.00314	CcSEcCtD
Dihydrocodeine—Rash—Cisplatin—testicular cancer	0.00167	0.00313	CcSEcCtD
Dihydrocodeine—Dermatitis—Cisplatin—testicular cancer	0.00167	0.00313	CcSEcCtD
Dihydrocodeine—Diarrhoea—Etoposide—testicular cancer	0.00166	0.00311	CcSEcCtD
Dihydrocodeine—Angiopathy—Doxorubicin—testicular cancer	0.00161	0.00301	CcSEcCtD
Dihydrocodeine—Dizziness—Etoposide—testicular cancer	0.0016	0.00301	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—testicular cancer	0.0016	0.003	CcSEcCtD
Dihydrocodeine—Vertigo—Methotrexate—testicular cancer	0.0016	0.003	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—testicular cancer	0.00159	0.00299	CcSEcCtD
Dihydrocodeine—Nausea—Cisplatin—testicular cancer	0.00157	0.00295	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—testicular cancer	0.00155	0.00291	CcSEcCtD
Dihydrocodeine—Convulsion—Methotrexate—testicular cancer	0.00154	0.00289	CcSEcCtD
Dihydrocodeine—Vomiting—Etoposide—testicular cancer	0.00154	0.00289	CcSEcCtD
Dihydrocodeine—Rash—Etoposide—testicular cancer	0.00153	0.00287	CcSEcCtD
Dihydrocodeine—Dermatitis—Etoposide—testicular cancer	0.00153	0.00287	CcSEcCtD
Dihydrocodeine—Headache—Etoposide—testicular cancer	0.00152	0.00285	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.0015	0.00282	CcSEcCtD
Dihydrocodeine—Vertigo—Epirubicin—testicular cancer	0.0015	0.00281	CcSEcCtD
Dihydrocodeine—Confusional state—Methotrexate—testicular cancer	0.00146	0.00275	CcSEcCtD
Dihydrocodeine—Convulsion—Epirubicin—testicular cancer	0.00144	0.00271	CcSEcCtD
Dihydrocodeine—Nausea—Etoposide—testicular cancer	0.00144	0.0027	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methotrexate—testicular cancer	0.00142	0.00267	CcSEcCtD
Dihydrocodeine—Skin disorder—Methotrexate—testicular cancer	0.00141	0.00265	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00141	0.00264	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methotrexate—testicular cancer	0.0014	0.00263	CcSEcCtD
Dihydrocodeine—Dry mouth—Epirubicin—testicular cancer	0.00139	0.0026	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—testicular cancer	0.00138	0.0026	CcSEcCtD
Dihydrocodeine—Confusional state—Epirubicin—testicular cancer	0.00137	0.00257	CcSEcCtD
Dihydrocodeine—Hypotension—Methotrexate—testicular cancer	0.00136	0.00255	CcSEcCtD
Dihydrocodeine—Convulsion—Doxorubicin—testicular cancer	0.00133	0.00251	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Epirubicin—testicular cancer	0.00133	0.0025	CcSEcCtD
Dihydrocodeine—Skin disorder—Epirubicin—testicular cancer	0.00132	0.00248	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Epirubicin—testicular cancer	0.00131	0.00247	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methotrexate—testicular cancer	0.0013	0.00245	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.0013	0.00244	CcSEcCtD
Dihydrocodeine—Dyspnoea—Methotrexate—testicular cancer	0.00129	0.00243	CcSEcCtD
Dihydrocodeine—Somnolence—Methotrexate—testicular cancer	0.00129	0.00242	CcSEcCtD
Dihydrocodeine—Dry mouth—Doxorubicin—testicular cancer	0.00128	0.00241	CcSEcCtD
Dihydrocodeine—Hypotension—Epirubicin—testicular cancer	0.00127	0.00238	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—testicular cancer	0.00127	0.00238	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00125	0.00235	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—testicular cancer	0.00123	0.00231	CcSEcCtD
Dihydrocodeine—Skin disorder—Doxorubicin—testicular cancer	0.00122	0.00229	CcSEcCtD
Dihydrocodeine—Paraesthesia—Epirubicin—testicular cancer	0.00122	0.00229	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00122	0.00228	CcSEcCtD
Dihydrocodeine—Dyspnoea—Epirubicin—testicular cancer	0.00121	0.00227	CcSEcCtD
Dihydrocodeine—Somnolence—Epirubicin—testicular cancer	0.00121	0.00227	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methotrexate—testicular cancer	0.0012	0.00225	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00119	0.00223	CcSEcCtD
Dihydrocodeine—Hypotension—Doxorubicin—testicular cancer	0.00117	0.0022	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00117	0.0022	CcSEcCtD
Dihydrocodeine—Constipation—Epirubicin—testicular cancer	0.00116	0.00218	CcSEcCtD
Dihydrocodeine—Urticaria—Methotrexate—testicular cancer	0.00115	0.00216	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methotrexate—testicular cancer	0.00115	0.00215	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—testicular cancer	0.00113	0.00212	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—testicular cancer	0.00112	0.0021	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Epirubicin—testicular cancer	0.00112	0.0021	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—testicular cancer	0.00112	0.0021	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00111	0.00209	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00109	0.00204	CcSEcCtD
Dihydrocodeine—Urticaria—Epirubicin—testicular cancer	0.00108	0.00203	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—testicular cancer	0.00108	0.00202	CcSEcCtD
Dihydrocodeine—Abdominal pain—Epirubicin—testicular cancer	0.00107	0.00202	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Doxorubicin—testicular cancer	0.00104	0.00194	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00103	0.00193	CcSEcCtD
Dihydrocodeine—Pruritus—Methotrexate—testicular cancer	0.00103	0.00193	CcSEcCtD
Dihydrocodeine—Urticaria—Doxorubicin—testicular cancer	0.000999	0.00187	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—testicular cancer	0.000994	0.00187	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methotrexate—testicular cancer	0.000993	0.00186	CcSEcCtD
Dihydrocodeine—Pruritus—Epirubicin—testicular cancer	0.000961	0.0018	CcSEcCtD
Dihydrocodeine—Dizziness—Methotrexate—testicular cancer	0.00096	0.0018	CcSEcCtD
Dihydrocodeine—Diarrhoea—Epirubicin—testicular cancer	0.00093	0.00174	CcSEcCtD
Dihydrocodeine—Vomiting—Methotrexate—testicular cancer	0.000923	0.00173	CcSEcCtD
Dihydrocodeine—Rash—Methotrexate—testicular cancer	0.000915	0.00172	CcSEcCtD
Dihydrocodeine—Dermatitis—Methotrexate—testicular cancer	0.000915	0.00172	CcSEcCtD
Dihydrocodeine—Headache—Methotrexate—testicular cancer	0.00091	0.00171	CcSEcCtD
Dihydrocodeine—Dizziness—Epirubicin—testicular cancer	0.000899	0.00169	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—testicular cancer	0.00089	0.00167	CcSEcCtD
Dihydrocodeine—Vomiting—Epirubicin—testicular cancer	0.000864	0.00162	CcSEcCtD
Dihydrocodeine—Nausea—Methotrexate—testicular cancer	0.000862	0.00162	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—testicular cancer	0.00086	0.00161	CcSEcCtD
Dihydrocodeine—Rash—Epirubicin—testicular cancer	0.000857	0.00161	CcSEcCtD
Dihydrocodeine—Dermatitis—Epirubicin—testicular cancer	0.000856	0.00161	CcSEcCtD
Dihydrocodeine—Headache—Epirubicin—testicular cancer	0.000851	0.0016	CcSEcCtD
Dihydrocodeine—Dizziness—Doxorubicin—testicular cancer	0.000831	0.00156	CcSEcCtD
Dihydrocodeine—Nausea—Epirubicin—testicular cancer	0.000807	0.00151	CcSEcCtD
Dihydrocodeine—Vomiting—Doxorubicin—testicular cancer	0.000799	0.0015	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—testicular cancer	0.000793	0.00149	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—testicular cancer	0.000792	0.00149	CcSEcCtD
Dihydrocodeine—Headache—Doxorubicin—testicular cancer	0.000788	0.00148	CcSEcCtD
Dihydrocodeine—Nausea—Doxorubicin—testicular cancer	0.000747	0.0014	CcSEcCtD
